Arcturus Therapeutics (NASDAQ:ARCT) used a presentation at Guggenheim’s 2026 Emerging Outlook Biotech Summit to highlight ...

Arcturus Therapeutics now centers on ARCT-032 (cystic fibrosis) and ARCT-810 (OTC deficiency), with Covid assets as secondary ...

The Arcturus COVID-19 variant has arrived in the United States and is here to stay, according to experts. While it's unclear whether it will drive a summer surge, some doctors are warning that the ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of liver and respiratory rare disease ...

Here are 9 thing to know about the variant, according to AdventHealth: 1. According to health officials, COVID-19 is still a leading cause of death around the world, including in the United States ...

Women walk past a coronavirus (COVID-19) themed mural on a street in Mumbai, India, March 28, 2023. REUTERS/Francis Mascarenhas A new coronavirus subvariant, XBB. 1.16, has been designated as a ...

Los Angeles County Department of Public Health confirmed three cases of the Arcturus strain with "observational data" suggesting that those infected may be likely to experience pink eye Alexis Jones ...

A new subvariant of COVID-19 is proliferating in the US and is now responsible for nearly 10% of all new cases, according to alerts from the Centers for Disease Control and Prevention and the World ...